Time is Running out for Innovation Awards
The deadline for nominations for the Innovations in Pharma Science Awards is here. Check out http://pharmtech.com/Innovations to nominate your company's work in one of five areas by next week
Iselin, NJ (Aug. 28)-It’s no secret that industry pipelines are thin at the moment. But what about innovations in pharmaceutical science? Are companies keeping up with the times to develop new ways of testing, delivering, formulating, analyzing, or manufacturing drugs? Pharmaceutical Technology would like to hear from you. In fact, we launched a call for nominations for the 2008 Innovations in Pharma Science Awards earlier this summer. The awards will honor achievements in the pharmaceutical sciences, specifically in these five areas:
- Drug delivery (solid dosage and parenteral forms)
- Formulation development (solid dosage and parenteral forms)
- Dosage-form manufacturing (solid dosage and parenteral forms)
- Pharmaceutical analysis
- API synthesis and manufacturing (small molecules and biologics).
But the deadline for nominations is here. Check out pharmtech.com/Innovations to nominate your company's work in one of five areas by next week. The winners will be announced in the December issue.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
